Atlas Trials

A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer

Clinical trial NCT02428270 · COMPLETED

Trial details

NCT number
NCT02428270
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerAdenocarcinoma
Start date
2016-04-01
Primary completion
2017-06-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.